Magnus Gisslen

Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017
L. Naver, J. Albert, C. Carlander, L. Flamholc, Magnus Gisslén et al.
Infectious Diseases, Journal article 2018
Journal article

Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration
A. Calcagno, C. Pinnetti, A. De Nicolo, E. Scarvaglieri, Magnus Gisslén et al.
British Journal of Clinical Pharmacology, Journal article 2018
Journal article

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
Erik Sörstedt, C. Carlander, L. Flamholc, B. Hejdeman, V. Svedhem et al.
International Journal of Antimicrobial Agents, Journal article 2018
Journal article

Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
E. Andersson, A. Nordquist, J. Esbjörnsson, L. Flamholc, Magnus Gisslén et al.
AIDS, Journal article 2018
Journal article

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
P. D. Burbelo, R. W. Price, Lars Hagberg, H. Hatano, S. Spudich et al.
Journal of Infectious Diseases, Journal article 2018
Journal article

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole et al.
The Journal of infectious diseases, Journal article 2018
Journal article

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Elham Rahimy, Fang-Yong Li, Lars Hagberg, Dietmar Fuchs, Kevin Robertson et al.
The Journal of infectious diseases, Journal article 2017
Journal article

Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1 DNA
Tomas Mellberg, Jon Krabbe, Maria Buzon, Ulrika Noborg, Magnus Lindh et al.
International Journal of Virology and AIDS, Journal article 2017
Journal article

High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid
T. Booiman, F. W. Wit, I. Maurer, D. De Francesco, C. A. Sabin et al.
Open Forum Infectious Diseases, Journal article 2017
Journal article

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.
Aylin Yilmaz, Kaj Blennow, Lars Hagberg, Staffan Nilsson, Richard W Price et al.
Expert review of molecular diagnostics, Journal article 2017
Journal article

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013.
Lars Navér, Jan Albert, Ylva Böttiger, Christina Carlander, Leo Flamholc et al.
Scandinavian journal of infectious diseases, Journal article 2014
Journal article

Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection
J. Suh, E. Sinclair, J. Peterson, E. Lee, T. C. Kyriakides et al.
Journal of Neuroinflammation, Journal article 2014
Journal article

Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation
V. Dahl, J. Peterson, D. Fuchs, Magnus Gisslén, S. Palmer et al.
Aids, Journal article 2014
Journal article

Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
J. Albert, T. Berglund, Magnus Gisslén, P. Groon, A. Sonnerborg et al.
Scandinavian Journal of Infectious Diseases, Journal article 2014
Journal article

An example of genetically distinct HIV-1 variants in cerebrospinal fluid and plasma during suppressive therapy.
Viktor Dahl, Magnus Gisslén, Lars Hagberg, Julia Peterson, Wei Shao et al.
The Journal of infectious diseases, Journal article 2014
Journal article

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades.
Ujjwal Neogi, Amanda Häggblom, Michele Santacatterina, Göran Bratt, Magnus Gisslén et al.
PloS one, Journal article 2014
Journal article

Treatment of HIV in the Central Nervous System
Aylin Yilmaz, Magnus Gisslén
Seminars in Neurology, Journal article 2014
Journal article

Evolving Character of Chronic Central Nervous System HIV Infection
Richard W. Price, Serena S. Spudich, Julia Peterson, Sarah Joseph, Dietmar Fuchs et al.
Seminars in Neurology, Journal article 2014
Journal article

Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral Therapy
J. Vesterbacka, P. Nowak, B. Barqasho, S. Abdurahman, J. Nystrom et al.
PLoS ONE, Journal article 2013
Journal article

Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial.
Lars-Magnus Andersson, Jan Vesterbacka, Anders Blaxhult, Leo Flamholc, Staffan Nilsson et al.
Scandinavian journal of infectious diseases, Journal article 2013
Journal article